acebutolol and isoniazid

acebutolol has been researched along with isoniazid in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jack, DB1
Gifford, C; Hagemeier, C; Lucas, S; Mushtaq, A; Payton, M; Pinter, K; Schartau, P; Sim, E1
Kadota, K1

Reviews

2 review(s) available for acebutolol and isoniazid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Design of Spray-dried Porous Particles for Sugar-based Dry Powder Inhaler Formulation].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2018, Volume: 138, Issue:9

    Topics: Administration, Inhalation; Antitubercular Agents; Carboxylic Acids; Dextrins; Drug Compounding; Drug Delivery Systems; Drug Design; Dry Powder Inhalers; Ethanol; Excipients; Humans; Hydrophobic and Hydrophilic Interactions; Isoniazid; Maltose; Naphthalenes; Particle Size; Porosity; Powders; Rifampin; Solutions; Sucrose

2018

Other Studies

8 other study(ies) available for acebutolol and isoniazid

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Statistical analysis of polymorphic drug metabolism data using the Rosin Rammler Sperling Weibull distribution.
    European journal of clinical pharmacology, 1983, Volume: 25, Issue:4

    Topics: Acebutolol; Africa; Debrisoquin; Humans; Isoniazid; Metoprolol; Polymorphism, Genetic; Sparteine; Statistics as Topic

1983
Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis.
    Microbiology (Reading, England), 2001, Volume: 147, Issue:Pt 12

    Topics: Acebutolol; Amino Acid Sequence; Antibodies, Bacterial; Antibody Specificity; Antitubercular Agents; Arylamine N-Acetyltransferase; Drug Resistance, Bacterial; Isoniazid; Molecular Sequence Data; Mycobacterium smegmatis; Mycobacterium tuberculosis; Recombinant Proteins; Sequence Homology, Amino Acid

2001